Adenovirus type 5 exerts multiple effects on the expression and activity of cytosolic phospholipase A2, cyclooxygenase-2, and prostaglandin synthesis

Journal of Immunology

Volumn 179, Issue 6, 2007, Pages 4170-4179

  Culver, Carolyn A ^a   Laster, Scott M ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; N (4 METHOXYPHENYLACETYL)DEHYDROALANINE; PROSTAGLANDIN; PROSTAGLANDIN E2; UBIQUITIN PROTEIN LIGASE E3; ARACHIDONIC ACID; GROUP IV PHOSPHOLIPASES A2; PHOSPHOLIPASE A; PROSTACYCLIN; TRITIUM; UNCLASSIFIED DRUG;

ADENOVIRUS 5; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HUMAN ADENOVIRUS; IMMUNOLOGY; INTRACELLULAR FLUID; METABOLISM; MOUSE; PROTEIN TRANSPORT; SECRETION; TUMOR CELL LINE; VIROLOGY;

ADENOVIRUSES, HUMAN; ANIMALS; ARACHIDONIC ACID; CELL LINE; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME ACTIVATION; EPOPROSTENOL; FIBROBLASTS; HUMANS; INTRACELLULAR FLUID; MICE; PHOSPHOLIPASES A; PROSTAGLANDINS; PROTEIN TRANSPORT; TRITIUM;

EID: 35748953446     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.6.4170     Document Type: Article

References (76)

1. Kudo, I., and M. Murakami. 2002. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 68-69: 3-58.
2. Chen, Q. R., C. Miyaura, S. Higashi, M. Murakami, I. Kudo, S. Saito, T. Hiraide, Y. Shibasaki, and T. Suda. 1997. Activation of cytosolic phospholipase A2 by platelet-derived growth factor is essential for cyclooxygenase-2-dependent prostaglandin E2 synthesis in mouse osteoblasts cultured with interleukin-1. J. Biol. Chem. 272: 5952-5958.
3. Harris, S. G., J. Padilla, L. Koumas, D. Ray, and R. P. Phipps. 2002. Prostaglandins as modulators of immunity. Trends Immunol. 23: 144-150.
4. Van der Pouw Kraan, T. C., L. C. Boeije, R. J. Smeenk, J. Wijdenes, and L. A. Aarden. 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181: 775-779.
5. Van der Pouw Kraan, T. C., L. C. Boeije, A. Snijders, R. J. Smeenk, J. Wijdenes, and L. A. Aarden. 1996. Regulation of IL-12 production by human monocytes and the influence of prostaglandin E2. Ann. NY Acad. Sci. 795: 147-157.
6. Takayama, K., G. Garcia-Cardena, G. K. Sukhova, J. Comander, M. A. Gimbrone, Jr., and P. Libby. 2002. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J. Biol. Chem. 277: 44147-44154.
7. Brian, J. E., Jr., S. A. Moore, and F. M. Faraci. 1998. Expression and vascular effects of cyclooxygenase-2 in brain. Stroke 29: 2600-2606.
8. Vassiliou, E., V. Sharma, H. Jing, F. Sheibanie, and D. Ganea. 2004. Prostaglandin E2 promotes the survival of bone marrow-derived dendritic cells. J. Immunol. 173: 6955-6964.
9. Kabashima, K., D. Sakata, M. Nagamachi, Y. Miyachi, K. Inaba, and S. Narumiya. 2003. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9: 744-749.
10. 2 regulates the migratory capacity of specific DC subsets. Blood 100: 1362-1372.
11. Son, Y., T. Ito, Y. Ozaki, T. Tanijiri, T. Yokoi, K. Nakamura, M. Takebayashi, R. Amakawa, and S. Fukuhara. 2006. Prostaglandin E is a negative regulator on human plasmacytoid dendritic cells. Immunology 119: 36-42.
12. Hammad, H., H. J. de Heer, T. Soullie, H. C. Hoogsteden, F. Trottein, and B. N. Lambrecht. 2003. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. J. Immunol. 171: 3936-3940.
13. Nencioni, A., K. Lauber, F. Grunebach, W. Brugger, C. Denzlinger, S. Wesselborg, and P. Brossart. 2002. Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-γ-independent mechanism: regulation by inflammatory and T cell-derived stimuli. Exp. Hematol. 30: 1020-1028.
14. Garrone, P., L. Galibert, F. Rousset, S. M. Fu, and J. Banchereau. 1994. Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen. J. Immunol. 152: 4282-4290.
15. 2 receptor expression. Hum. Immunol. 61: 684-696.
16. Steer, S. A., and J. A. Corbett. 2003. The role and regulation of COX-2 during viral infection. Viral Immunol. 16: 447-460.
17. Stephenson, D. T., C. A. Lemere, D. J. Selkoe, and J. A. Clemens. 1996. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol. Dis. 3: 51-63.
18. Kalyvas, A., and S. David. 2004. Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron 41: 323-335.
19. Hierholzer, J. C. 1992. Adenoviruses in the immunocompromised host. Clin. Microbiol. Rev. 5: 262-274.
20. Garnett, C. T., D. Erdman, W. Xu, and L. R. Gooding. 2002. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J. Virol. 76: 10608-10616.
21. Beier, D. C., J. H. Cox, D. R. Vining, P. Cresswell, and V. H. Engelhard. 1994. Association of human class I MHC alleles with the adenovirus E3/19K protein. J. Immunol. 152: 3862-3872.
22. Gooding, L. R., L. W. Elmore, A. E. Tollefson, H. A. Brady, and W. S. Wold. 1988. A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53: 341-346.
23. Shisler, J., C. Yang, B. Walter, C. F. Ware, and L. R. Gooding. 1997. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J. Virol. 71: 8299-8306.
24. Horwitz, M. S. 2001. Adenovirus immunoregulatory genes and their cellular targets. Virology 279: 1-8.
25. Liu, Q., and D. A. Muruve. 2003. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 10: 935-940.
26. Jones, N., and T. Shenk. 1979. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17: 683-689.
27. Brady, H. A., A. Scaria, and W. S. Wold. 1992. Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus. J. Virol. 66: 5914-5923.
28. Leslie, C. C., D. R. Voelker, J. Y. Channon, M. M. Wall, and P. T. Zelarney. 1988. Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7. Biochim. Biophys. Acta 963: 476-492.
29. Voelkel-Johnson, C., T. E. Thorne, and S. M. Laster. 1996. Susceptibility to TNF in the presence of inhibitors of transcription or translation is dependent on the activity of cytosolic phospholipase A2 in human melanoma tumor cells. J. Immunol. 156: 201-207.
30. Duerksen-Hughes, P., W. S. Wold, and L. R. Gooding. 1989. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 143: 4193-4200.
31. Thorne, T. E., C. Voelkel-Johnson, W. M. Casey, L. W. Parks, and S. M. Laster. 1996. The activity of cytosolic phospholipase A2 is required for the lysis of adenovirus-infected cells by tumor necrosis factor. J. Virol. 70: 8502-8507.
32. O'Brien, J. B., D. L. Piddington, C. Voelkel-Johnson, D. J. Richards, L. A. Hadley, and S. M. Laster. 1998. Sustained phosphorylation of cytosolic phospholipase A2 accompanies cycloheximide- and adenovirus-induced susceptibility to TNF. J. Immunol. 161: 1525-1532.
33. Draper, D. W., V. G. Harris, C. A. Culver, and S. M. Laster. 2004. Calcium and its role in the nuclear translocation and activation of cytosolic phospholipase A2 in cells rendered sensitive to TNF-induced apoptosis by cycloheximide. J. Immunol. 172: 2416-2423.
34. Seno, K., T. Okuno, K. Nishi, Y. Murakami, F. Watanabe, T. Matsuura, M. Wada, Y. Fujii, M. Yamada, T. Ogawa, et al. 2000. Pyrrolidine inhibitors of human cytosolic phospholipase A2. J. Med. Chem. 43: 1041-1044.
35. Lin, L. L., M. Wartmann, A. Y. Lin, J. L. Knopf, A. Seth, and R. J. Davis. 1993. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72: 269-278.
36. Gijon, M. A., D. M. Spencer, A. R. Siddiqi, J. V. Bonventre, and C. C. Leslie. 2000. Cytosolic phospholipase A2 is required for macrophage arachidonic acid release by agonists that do and do not mobilize calcium: novel role of mitogen-activated protein kinase pathways in cytosolic phospholipase A2 regulation. J. Biol. Chem. 275: 20146-20156.
37. 2+-dependent translocation domain with homology to PKC and GAP. Cell 65: 1043-1051.
38. Wheeler-Jones, C., R. Abu-Ghazaleh, R. Cospedal, R. A. Houliston, J. Martin, and I. Zachary. 1997. Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett. 420: 28-32.
39. Fernandez-Soria, V., M. E. Lleonart, M. Diaz-Fuertes, R. Villuendas, R. Sanchez-Prieto, A. Fabra, and Y. C. S. Ramon. 2006. Adenovirus E1A orchestrates the urokinase-plasminogen activator system and up-regulates PAI-2 expression, supporting a tumor suppressor effect. Int. J. Oncol. 28: 143-148.
40. Mason, D. X., D. Keppler, J. Zhang, T. J. Jackson, Y. R. Seger, S. Matsui, F. Abreo, J. K. Cowell, G. J. Hannon, S. W. Lowe, and A. W. Lin. 2006. Defined genetic events associated with the spontaneous in vitro transformation of ElA/ Ras-expressing human IMR90 fibroblasts. Carcinogenesis 27: 350-359.
41. Frese, S., M. Schaper, J. R. Kuster, D. Miescher, M. Jaattela, T. Buehler, and R. A. Schmid. 2003. Cell death induced by down-regulation of heat shock protein 70 in lung cancer cell lines is p53-independent and does not require DNA cleavage. J. Thorac. Cardiovasc. Surg. 126: 748-754.
42. Das, S., S. Nama, S. Antony, and K. Somasundaram. 2005. p73 β-expressing recombinant adenovirus: a potential anticancer agent. Cancer Gene Ther. 12: 417-426.
43. Crofford, L. J., K. T. McDonagh, S. Guo, H. Mehta, H. Bian, L. M. Petruzelli, and B. J. Roessler. 2005. Adenovirus binding to cultured synoviocytes triggers signaling through MAPK pathways and induces expression of cyclooxygenase-2. J. Gene Med. 7: 288-296.
44. Hirschowitz, E. A., G. E. Hidalgo, and D. E. Doherty. 2002. Induction of cyclooxygenase-2 in non-small cell lung cancer cells by adenovirus vector information. Chest 121: 32S.
45. Hirschowitz, E., G. Hidalgo, and D. Doherty. 2002. Induction of cyclo-oxygenase-2 in non-small cell lung cancer cells by infection with DeltaE1, DeltaE3 recombinant adenovirus vectors. Gene Ther. 9: 81-84.
46. Ongradi, J., and A. Telekes. 1990. Relationship between the prostaglandin cascade and virus infection. Acta Virol. 34: 380-400.
47. Betz, M., and B. S. Fox. 1991. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146: 108-113.
48. Ludwig, S. L., J. F. Brundage, P. W. Kelley, R. Nang, C. Towle, D. P. Schnurr, L. Crawford-Miksza, and J. C. Gaydos. 1998. Prevalence of antibodies to adenovirus serotypes 4 and 7 among unimmunized US Army trainees: results of a retrospective nationwide seroprevalence survey. J. Infect. Dis. 178: 1776-1778.
49. Hernandez, M., S. L. Burillo, M. S. Crespo, and M. L. Nieto. 1998. Secretory phospholipase A2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1. J. Biol. Chem. 273: 606-612.
50. Fonteh, A. N., G. Atsumi, T. LaPorte, and F. H. Chilton. 2000. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells. J. Immunol. 165: 2773-2782.
51. Liu, S. J., and J. McHowat. 1998. Stimulation of different phospholipase A2 isoforms by TNF-α and IL-1β in adult rat ventricular myocytes. Am. J. Physiol. 275: H1462-H1472.
52. Sjursen, W., O. L. Brekke, and B. Johansen. 2000. Secretory and cytosolic phospholipase A2 regulate the long-term cytokine-induced eicosanoid production in human keratinocytes. Cytokine 12: 1189-1194.
53. Shao, R., M. C. Hu, B. P. Zhou, S. Y. Lin, P. J. Chiao, R. H. von Lindern, B. Spohn, and M. C. Hung. 1999. E1A sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of IκB kinases and nuclear factor κB activities. J. Biol. Chem. 274: 21495-21498.
54. Nakao, S., Y. Ogata, E. Shimizu-Sasaki, M. Yamazaki, S. Furuyama, and H. Sugiya. 2000. Activation of NFκB is necessary for IL-1δ-induced cyclooxygenase-2 (COX-2) expression in human gingival fibroblasts. Mol. Cell. Biochem. 209: 113-118.
55. Sheridan, A. M., A. Sapirstein, N. Lemieux, B. D. Martin, D. K. Kim, and J. V. Bonventre. 2001. Nuclear translocation of cytosolic phospholipase A2 is induced by ATP depletion. J. Biol. Chem. 276: 29899-29905.
56. Fatima, S., F. A. Yaghini, A. Ahmed, Z. Khandekar, and K. U. Malik. 2003. CaM kinase IIα mediates norepinephrine-induced translocation of cytosolic phospholipase A2 to the nuclear envelope. J. Cell Sci. 116: 353-365.
57. Sierra-Honigmann, M. R., J. R. Bradley, and J. S. Pober. 1996. "Cytosolic" phospholipase A2 is in the nucleus of subconfluent endothelial cells but confined to the cytoplasm of confluent endothelial cells and redistributes to the nuclear envelope and cell junctions upon histamine stimulation. Lab. Invest. 74: 684-695.
58. Schievella, A. R., M. K. Regier, W. L. Smith, and L. L. Lin. 1995. Calciummediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. J. Biol. Chem. 270: 30749-30754.
59. Peters-Golden, M., K. Song, T. Marshall, and T. Brock. 1996. Translocation of cytosolic phospholipase A2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis. Biochem. J. 318: 797-803.
60. Liu, J., T. Takano, J. Papillon, A. Khadir, and A. V. Cybulsky. 2001. Cytosolic phospholipase A2-α associates with plasma membrane, endoplasmic reticulum and nuclear membrane in glomerular epithelial cells. Biochem. J. 353: 79-90.
61. Evans, J. H., D. M. Spencer, A. Zweifach, and C. C. Leslie. 2001. Intracellular calcium signals regulating cytosolic phospholipase A2 translocation to internal membranes. J. Biol. Chem. 276: 30150-30160.
62. Tashiro, S., T. Sumi, N. Uozumi, T. Shimizu, and T. Nakamura. 2004. B-Myb-dependent regulation of c-Myc expression by cytosolic phospholipase A2. J. Biol. Chem. 279: 17715-17722.
63. Ralston, R., and J. M. Bishop. 1983. The protein products of the myc and myb oncogenes and adenovirus E1a are structurally related. Nature 306: 803-806.
64. Ben-Ze'ev, A., L. E. Babiss, and P. B. Fisher. 1986. Cleavage of vimentin in dense cell cultures: inhibition upon transformation by type 5 adenovirus. Exp. Cell Res. 166: 47-62.
65. Jackson, P., and A. J. Bellett. 1989. Relationship between organization of the actin cytoskeleton and the cell cycle in normal and adenovirus-infected rat cells. J. Virol. 63: 311-318.
66. Bellett, A. J., P. Jackson, E. T. David, E. J. Bennett, and B. Cronin. 1989. Functions of the two adenovirus early E1A proteins and their conserved domains in cell cycle alteration, actin reorganization, and gene activation in rat cells. J. Virol. 63: 303-310.
67. 2α. J. Biol. Chem. 275: 1161-1168.
68. Fatima, S., F. A. Yaghini, Z. Pavicevic, S. Kalyankrishna, N. Jafari, E. Luong, A. Estes, and K. U. Malik. 2005. Intact actin filaments are required for cytosolic phospholipase A2 translocation but not for its activation by norepinephrine in vascular smooth muscle cells. J. Pharmacol. Exp. Ther. 313: 1017-1026.
69. Huwiler, A., B. Johansen, A. Skarstad, and J. Pfeilschifter. 2001. Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release. FASEB J. 15: 7-9.
70. Kanj, S. S., N. Dandashi, A. El-Hed, H. Harik, M. Maalouf, L. Kozhaya, T. Mousallem, A. E. Tollefson, W. S. Wold, C. E. Chalfant, and G. S. Dbaibo. 2006. Ceramide regulates SR protein phosphorylation during adenoviral infection. Virology 345: 280-289.
71. Pettus, B. J., J. Bielawski, A. M. Porcelli, D. L. Reames, K. R. Johnson, J. Morrow, C. E. Chalfant, L. M. Obeid, and Y. A. Hannun. 2003. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-α. FASEB J. 17: 1411-1421.
72. Pettus, B. J., A. Bielawska, S. Spiegel, P. Roddy, Y. A. Hannun, and C. E. Chalfant. 2003. Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release. J. Biol. Chem. 278: 38206-38213.
73. Pettus, B. J., A. Bielawska, P. Subramanian, D. S. Wijesinghe, M. Maceyka, C. C. Leslie, J. H. Evans, J. Freiberg, P. Roddy, Y. A. Hannun, and C. E. Chalfant. 2004. Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J. Biol. Chem. 279: 11320-11326.
74. Schaack, J. 2005. Induction and inhibition of innate inflammatory responses by adenovirus early region proteins. Viral Immunol. 18: 79-88.
75. Liu, T., W. Zaman, B. S. Kaphalia, G. A. Ansari, R. P. Garofalo, and A. Casola. 2005. RSV-induced prostaglandin E2 production occurs via cPLA2 activation: role in viral replication. Virology 343: 12-24.
76. Savard, M., C. Belanger, M. J. Tremblay, N. Dumais, L. Flamand, P. Borgeat, and J. Gosselin. 2000. EBV suppresses prostaglandin E2 biosynthesis in human monocytes. J. Immunol. 164: 6467-6473.